Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells (Q39386176)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells |
scientific article |
Statements
1 reference
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells (English)
1 reference
Joshua Bliesath
1 reference
Nanni Huser
1 reference
Mayuko Omori
1 reference
Daniel Bunag
1 reference
Chris Proffitt
1 reference
Nicole Streiner
1 reference
Caroline Ho
1 reference
Adam Siddiqui-Jain
1 reference
Sean E O'Brien
1 reference
John K C Lim
1 reference
David M Ryckman
1 reference
Kenna Anderes
1 reference
William G Rice
1 reference
Denis Drygin
1 reference
2 March 2012
1 reference
1 reference
322
1 reference
1
1 reference
113-118
1 reference
Identifiers
1 reference
1 reference